Kobo Biotech Ltd.

Reverse DCF

Earnings

Discount Rate (%)

Terminal Multiple

5 YEAR

10 YEAR

20 YEAR

Implied Growth Rate over a 5 year period*

Implied Growth Rate over a 10 year period*

Implied Growth Rate over a 20 year period*

*Implied Growth calculated using Newton-Rhapson method.

Learn how to use Reverse DCF

FAQs on Kobo Biotech Ltd. Financials

How strong is Kobo Biotech balance sheet?

Kobo Biotech balance sheet is weak and might have solvency issues

Is the debt of Kobo Biotech increasing or decreasing?

Yes, The debt of Kobo Biotech is increasing.
Latest debt of Kobo Biotech is ₹140 Crs as of Mar-24.
This is greater than Mar-23 when it was ₹140 Crs.

Is the profitablity of Kobo Biotech improving?

Yes, profit is increasing.
The profit of Kobo Biotech is -₹5.46 Crs for TTM, -₹5.55 Crs for Mar 2023 and -₹15.23 Crs for Mar 2022.

Does Kobo Biotech pay decent dividends?

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Kobo Biotech latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

How has Kobo Biotech allocated its funds?

Companies resources are majorly tied in miscellaneous assets

View FAQ's On Shareholding

Kobo Biotech Ltd.

Has the share price of Kobo Biotech grown faster than its competition?

Is Kobo Biotech stock expensive?

How strong is Kobo Biotech balance sheet?

Is the debt of Kobo Biotech increasing or decreasing?

Is the profitablity of Kobo Biotech improving?

Does Kobo Biotech pay decent dividends?

How has Kobo Biotech allocated its funds?

Kobo Biotech Ltd.

Kobo Biotech Ltd.

Has the share price of Kobo Biotech grown faster than its competition?

Is Kobo Biotech stock expensive?

How strong is Kobo Biotech balance sheet?

Is the debt of Kobo Biotech increasing or decreasing?

Is the profitablity of Kobo Biotech improving?

Does Kobo Biotech pay decent dividends?

How has Kobo Biotech allocated its funds?

SIGN UP FOR FREE